510(k) Report

510(k) · Cleared

Cleared

Fitbit Irregular Rhythm Notifications

K212372510(k) TraditionalCleared Apr 8, 2022252-day reviewClass II21 CFR 870.2790

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Fitbit, Inc. · QDB Photoplethysmograph Analysis Software For Over-The-Counter Use

Cleared on Apr 8, 2022 as substantially equivalent to DEN180042 (Apple, Inc., 2018) after a 252-day review. Its family tree reaches back 1 generation to 2018. 1 later device descends from it.

Decided
Apr 8, 2022
Review
252 days
Class
Class II
Product code
QDB
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to DEN180042 (2018). 1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2025: 1 descendant clearedDEN180042 · Irregular Rhythm Notification Feature · Apple, Inc. · 2018201620182020202220242026
Descendants, by generation 1 generation forward: 1 descendant DEN180042 · Irregular Rhythm Notification Feature · Apple, Inc. · 20180
  1. Root · 1 generation backDEN180042 Irregular Rhythm Notification FeatureApple, Inc. · 2018
  2. This deviceK212372 Fitbit Irregular Rhythm NotificationsFitbit, Inc. · 2022
  3. Descendant · cites it directly · 0 of its ownK242967 Loss of Pulse DetectionFitbit · 2025

Most influential descendants

Showing 1 of 1 · See all
  • K242967Loss of Pulse DetectionFitbit · 2025 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1DEN180042Irregular Rhythm Notification FeatureApple, Inc.2018—
0 (this device)K212372Fitbit Irregular Rhythm NotificationsFitbit, Inc.2022—
+1K242967Loss of Pulse DetectionFitbit2025—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202510
FIG. 1 — Lineage of K212372, 2018–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QDB? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QDB device

  1. #1 K212516 IRNF Appscore 8.2 · 1 generation · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*DEN180042Irregular Rhythm Notification Feature
Summary page 4
…Regulatory Class: Class II Product Code: QDB - 21 CFR 870.2790 3. Predicate Device Apple Inc., Irregular Rhythm Notification Feature (DEN180042) 4. Indications for Use The Fitbit Irregular Rhythm Notifications is a software-only mobile medical application that…
Apple, Inc.2018—

Also cleared against DEN180042: 2 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K242967Loss of Pulse DetectionFitbit20250

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K242967 (Fitbit, 2025) has gone furthest, with 0 descendants of its own.
  • 2 other devices also cite its predicate DEN180042.

How does its category compare?

All QDB devices

QDB Photoplethysmograph Analysis Software For Over-The-Counter Use: FDA decisions, review times, recalls and adverse event reports over 20 years. 2022, this device’s year, is highlighted.

FDA decisions per year · QDB

1in 2023

2018: 12021: 12022: 22023: 1
2007high 2 (2022) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QDB

Too few QDB 510(k)s in any year since 2007 to give a median.

Recalls per year · QDB

No recall names QDB since 2007.

Adverse event reports per year · QDB

1in 2025

2025: 1
2007high 1 (2025) · low 0 (2007)2025

MAUDE reports naming product code QDB, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20181—00
20190—00
20200—00
20211—00
20222—00
20231—00
20240—00
20250—01
20260—0—

What is it indicated for?

The Fitbit Irregular Rhythm Notifications is a software-only mobile medical application that is intended to be used with compatible consumer wrist-worn products to analyze pulse rate data to identify episodes of irregular heart rhythms suggestive of atrial fibrillation (AFib) and provide a notification to the user. The Fitbit Irregular Rhythm Notifications is intended for over-the-counter (OTC) use. It is not intended to provide a notification on every…

Read the full statement (196 words)

The Fitbit Irregular Rhythm Notifications is a software-only mobile medical application that is intended to be used with compatible consumer wrist-worn products to analyze pulse rate data to identify episodes of irregular heart rhythms suggestive of atrial fibrillation (AFib) and provide a notification to the user.

The Fitbit Irregular Rhythm Notifications is intended for over-the-counter (OTC) use. It is not intended to provide a notification on every episode of irregular rhythm suggestive of AFib and the absence of a notification is not intended to indicate no disease process is present; rather the Fitbit Irregular Rhythm Notifications is intended to opportunistically surface a notification of possible AFib when sufficient data are available for analysis.

These data are only captured when the user is still. Along with the user’s risk factors, the Fitbit Irregular Rhythm Notifications can be used to supplement the decision for AFib screening. The Fitbit Irregular Rhythm Notifications is not intended to replace traditional methods of diagnosis or treatment.

The Fitbit Irregular Rhythm Notifications has not been tested for and is not intended for use in people under 22 years of age. It is also not intended for use in individuals previously diagnosed with AFib.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K212372: Fitbit Irregular Rhythm Notifications.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K212372

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026